Cargando…
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
The main aim of this study was to evaluate the ability of serum biomarkers to predict the worsening of retinal neurodysfunction in subjects with type 2 diabetes. For this purpose, we measured selected molecules (N-epsilon-carboxy methyl lysine (CML), laminin P1 (Lam-P1), and asymmetric dimethylargin...
Autores principales: | Hernández, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P., Aldington, Stephen J., Egan, Catherine, Frydkjaer-Olsen, Ulrik, García-Arumí, José, Gibson, Jonathan, Lang, Gabriele E., Lattanzio, Rosangela, Massin, Pascale, Midena, Edoardo, Ponsati, Berta, Ribeiro, Luísa, Scanlon, Peter, Cunha-Vaz, José, Simó, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231127/ https://www.ncbi.nlm.nih.gov/pubmed/32344735 http://dx.doi.org/10.3390/jcm9041233 |
Ejemplares similares
-
Short Report: Complications Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy
por: Scanlon, P H, et al.
Publicado: (2014) -
Epidemiological Issues in Diabetic Retinopathy
por: Scanlon, Peter H, et al.
Publicado: (2013) -
The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012) -
Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy
por: Midena, Edoardo, et al.
Publicado: (2021) -
The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010
por: Scanlon, Peter H, et al.
Publicado: (2013)